top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Incontinence



Most Common Factor

  • Weak pelvic floor muscles causing stress incontinence, urge incontinence, and overactive bladder (OAB)

  • UTI and constipation commonly contribute, especially in older adults

  • Types:

    • Stress: Weak sphincters leading to leakage with increased intra-abdominal pressure (e.g., coughing, laughing)

    • Urge: Overactive bladder (OAB) with involuntary detrusor contractions ± weak sphincters

    • Overflow: Poor bladder emptying due to detrusor underactivity or bladder outlet obstruction


Differential Diagnosis: DIAPPEERSSS


Delirium/dementiaInfection

Infection - UTI / interstitial cystitis

Atrophic vaginitis

Psychl (neuro) - MS, stroke, parkinsons, spinal cord inj, depression

Pharmaceuticals (anticholinergic inc TCA, diuretics, sedatives, opioids)

Excess fluids/weight - Alcohol, caffeine, ↑ intra-abdominal pressure

Endocrine - Diabetes (polyuria), hyperCa (polyuria, weak bladder)

Restricted mobility

Stool impaction

Sphincter weakness (childbirth, pelvic organ prolapse)

Sphincter blockage (bladder stone/tumour, BPH, prostate cancer, urethral stricture, ovarian tumour)


History

  • Type

    • Stress: Worse with coughing, sneezing

    • Urge: Sudden, strong need to void ± leakage

    • Overflow: Incomplete emptying, dribbling

  • Storage symptoms: Frequency, urgency, nocturia

  • Voiding symptoms: Hesitancy, dribbling, incomplete emptying

  • Severity: Frequency, pad use, impact on QoL


Key History Questions to Differentiate Causes

  • Dysuria

  • Haematuria

  • Vaginal dryness / postmenopausal

  • Medication use

  • Etoh/caffeine intake

  • Restricted mobility

  • Constipation

  • Previous childbirths, prolapse

  • Weight loss

  • Previous prostatic surgery

  • Family history prostate ca

  • Bone pain

  • Incomplete emptying


Additional Considerations

  • Anticholinergics: Increase muscle relaxation → may worsen overflow incontinence, especially in neurological patients (e.g., Parkinson’s, dementia)​

  • Urge incontinence → Often from bladder irritation (e.g., stones, infection, malignancy, atrophic vaginitis)


Examination


General Exam:

  • BMI: Obesity → Stress incontinence risk

  • Abdomen: Palpable bladder → Chronic retention, mass if suprapubic fullness

  • Neurological (Lower Limbs & Perineum): Assess for spinal cord pathology, MS, stroke


Women:

  • Pelvic exam: Atrophic vaginitis, pelvic organ prolapse

  • Pelvic floor strength: Ask patient to contract muscles

  • Cough test: Observe for stress incontinence


Men:

  • Genital exam: Phimosis, narrow meatus

  • DRE: Prostate size, consistency (BPH, malignancy)


Investigations:

  • US for KUB and PVR (>100mL abnorm)

  • Urine MCS

  • Bladder diary

  • Fasting BSL

  • eGFR (assess kid inj, more in men if susp retention)

  • STI screen

  • PSA


Key Notes:

  • Pelvic organ prolapse & atrophic vaginitis → Assess in women

  • PVR is crucial for differentiating overflow incontinence

  • Neurological causes → Consider in abnormal lower limb reflexes/perineal sensory loss

  • Bladder diary helps distinguish urge, stress, mixed, and overflow incontinence


Management


Non-Pharmacological 

  • Bladder diary to identify patterns and triggers

  • Bladder training / timed voiding to increase bladder capacity and reduce urgency

  • Avoid excessive fluid intake, especially after midday

  • Avoid bladder diuretics (e.g., caffeine, alcohol) that increase urine production

  • Avoid bladder irritants (e.g., spicy foods, artificial sweeteners, carbonated drinks)

  • Pelvic floor exercises (e.g., Kegel exercises) to strengthen muscles and improve control

  • Maintain regular soft bowel motions with a high-fibre diet to prevent constipation, which worsens incontinence

  • Weight loss in overweight/obese patients to reduce intra-abdominal pressure and symptom severity

  • Smoking cessation as smoking worsens incontinence via chronic cough and bladder irritation​


Pharmacological 

  • Anticholinergics: Oxybutynin (patch formulation reduces dry mouth), solifenacin

  • Beta-adrenergic agonists: Mirabegron (useful in overactive bladder, fewer cognitive side effects than anticholinergics)

  • Vaginal oestrogens: Estradiol pessaries (limited evidence, but may improve urogenital atrophy in postmenopausal women)

  • Note: Laser ablation/resection of the prostate is as effective as TURP and may have fewer complications in selected patients


Benign Prostatic Hyperplasia (BPH) and Incontinence

  • All the above non-pharmacological strategies can be used for BPH-related incontinence

  • Mild BPH (IPSS <7): Non-pharmacological management alone may be sufficient

  • Alpha-blockers:

    • Tamsulosin, prazosin (risk of postural hypotension, dizziness, erectile dysfunction)

  • 5-alpha reductase inhibitors:

    • Dutasteride (can cause erectile dysfunction, reduced libido)

    • Combination therapy (tamsulosin + dutasteride = Duodart) for moderate to severe symptoms

  • Anticholinergics (e.g., oxybutynin, solifenacin) may be used in select cases with overactive bladder symptoms

  • Note: Consider using the International Prostate Symptom Score (IPSS) to guide management​

Bookmark Failed!

Bookmark Saved!

bottom of page